UBS Group »

Ionis Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Ionis Pharmaceuticals shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $24k 17k 1.38

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Ubs Group SHS (UBS)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A (V)

View all positions for UBS Group

Top funds holding Ionis Pharmaceuticals

Ing Investment Management
Deerfield Management Company
Camden Asset Management
Lazard Asset Management
Wolverine Asset Management
Wellington Management Company
MacKay Shields
Calamos Advisors
BlackRock
DLD Asset Management
CSS
Linden Advisors
Morgan Stanley
State Street Corporation
Universal- Beteiligungs- und Servicegesellschaft mbH

View all funds holding Ionis Pharmaceuticals